Inhibition of transplant coronary arteriosclerosis in rabbits by chronic estradiol treatment is associated with abolition of MHC class II antigen expression

Circulation

Volumn 94, Issue 12, 1996, Pages 3355-3361

  Lou, Hong ^a   Kodama, Teruaki ^a   Zhao, Ye Jun ^a   Maurice, Peter ^a   Wang, Yi Ning ^a   Katz, Nevin ^a   Foegh, Marie L ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

antigens; arteries; arteriosclerosis; rejection; transplantation

Indexed keywords

CYCLOSPORIN A; ESTRADIOL CIPIONATE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PLACEBO;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; ESTROGEN THERAPY; GRAFT REJECTION; HEART TRANSPLANTATION; INTRAMUSCULAR DRUG ADMINISTRATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0030454155     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.12.3355     Document Type: Article

References (48)

1. Saris GE, Moore KA, Schroeder JS, Hunt SA, Fowler MB, Valantine HB, Vegas RAH, Billingham ME. Cardiac transplantation: the Stanford experience in the cyclosporine era. J Thorac Cardiovasc Surg. 1994;108:240-252.
2. Adams DH, Wyner LR, Karnovsky MJ. Experimental graft arteriosclerosis. II: immuno-cytochemical analysis of lesion development. Transplantation. 1993;56:794-799.
3. Lundgren CH, Sawa H, Sobel BE, Fujii S, Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy. Circulation. 1994;90:1927-1934.
4. Tanaka H, Sukhova GK, Swanson SJ, Clinton SK, Ganz P, Cybulsky MI, Libhy P. Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation. 1993;88:1788-1803.
5. Kuwahara M, Jacobsson J, Kuwahara M, Kagan E, Ramwell PW, Foegh ML. Coronary artery ultrastructural changes in cardiac transplant arteriosclerosis in the rabbit. Transplantation. 1991;52:759-765.
6. Häyry P. Molecular pathology of acute and chronic rejection. Transplant Proc. 1994;26:3280-3284.
7. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone replacement therapy with various cardiovascular risk factors in post menopausal women. N Engl J Med. 1993;328:1069-1075.
8. Manolio TA, Furberg CD, Shemanski L, Psaty BM, O'Leary DH, Tracy RP, Bush TL, for the CHS Collaborative Research Group. Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. Circulation. 1993;88:2163-2171.
9. Kafonek SD. Postmenopausal hormone replacement therapy and cardiovascular risk reduction. Drugs. 1994;47(suppl 2):16-24.
10. Foegh ML, Rego A, Lou H. Katz N, Rainwell PW. Gender effects on myointimal hyperplasia. Transplant Proc. 1995;27:2070-2072.
11. Foegh ML, Khirabadi DS, Nakanishi T, Vargas R, Ramwell PW. Estradiol protects against experimental cardiac transplant atherosclerosis. Transplant Proc. 1987:19(suppl 5):90-95.
12. Cheng LP, Kuwahara M, Jacobsson J, Foegh ML. Inhibition of myointimal hyperplasia and macrophage infiltration by estradiol in aorta allografts. Transplantation. 1991;52:967-972.
13. Libby P, Swanson SJ, Tanaka H, Murray A, Schoen FJ, Pober J. Immunopathology of coronary arteriosclerosis in transplanted hearts. J Heart Lung Transplant. 1992;1(suppl pt 1):S5-6.
14. Young JB, Windsor N, Kleiman NS, Lowry R, Cocanougher B, Lawrence EC. The relationship of soluble interleukin-2 receptor levels to allograft arteriopathy after heart transplantation. J Heart Lung Transplant. 1992;11:S79-S82.
15. Costanzo-Nordin MR. Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility. J Heart Lung Transplant. 1992:11(suppl pt 1):S90-103.
16. Libby P, Tanaka H. The pathogenesis of coronary arteriosclerosis 'chronic rejection' in transplanted hearts. Clin Transplant. 1994;8:313-318.
17. Mehra MR, Stapleton DD, Ventura HO, Escobar A, Cassidy CA, Smart FW, Collins TJ, Ramee SR, White CJ. Influence of donor and recipient gender on cardiac allograft vasculopathy: an intravascular ultrasound study. Circulation. 1994:90(suppl II):II-78-II-82.
18. Okuyama R, Abo T, Seki S, Ohteki T, Sugiura K, Kusumi A, Kumagai K. Estrogen administration activates extrathymic T-cell differentiation in the liver. J Exp Med. 1992;175:661-669.
19. Shirshev SV, Shilov LL, Kevorkov NN. Effect of female sex steroids on the ability of splenocytes to form an adoptive immune response: role of prostaglandin F2alpha in the mechanisms of hormonal immunoregulation. Probl Endokrinol. 1994;40:47-49.
20. Tabibzadeh SS, Pondichery SG. Sex steroid receptors in lymphoid cells of human endometrium. Am J Clin Pathol. 1988;91:656-663.
21. Fox FS, Bond BL, Parslow TG. Estrogen regulates the IFN-garnma promoter. J Imnumol. 1991;146:4362-4367.
22. Parr MB, Kepple L, McDermott MR, Drew MD, Bozzola JJ, Parr EL. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab Invest. 1994;70:369-380.
23. Debout C, Lefroit-Joliy M, Neveu T, Izard J. 17β-Estradiol affects the expression of guinea pig blood leukocyte MHC antigens. J Steroid Biochem Mol Biol. 1991;38:695-701.
24. Tabibzadeh SS, Sivarajah A, Carpenter D, Ohlsson-Wilhelm BA, Satyaswaroop PG. Modulation of HLA-DR expression in epithelial cells by interleukin-1 and estradiol-17β. J Clin Endocrinol Metab. 1990;71:740-747.
25. 2 in porcine coronary artery. Circulation. 1995;91:2619-2626.
26. Lichtlen PR, Hugenholtz PG, Rafflenbeul W, Hecker H, Jost S, Deckers JW. Retardation of angiographic progression of coronary artery disease by nifedipine: results of the International Nifedipine Trial on Antiarteriosclerotic Therapy (INTACT). Lancet. 1990;335:1109-1113.
27. Ardehali A, Laks H, Drinkwater DC, Ziv E, Drake TA. Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy. Circulation. 1995;92:450-456.
28. Wilson SE, Lloyd SA. Epidermal growth factor and its receptor, basic fibroblast growth factors, transforming growth factor beta-1, and interleukin-1 alpha mRNA production in human corneal endothelial cells. Invest Ophthalmol Vis Sci. 1991;32:2747-2756.
29. Grant M, King GL. IGF-I and blood vessels. Diabetes Rev. 1995;3:113-128.
30. Banskota NK, Carpentier JL, King GL. Processing and release of insulin and insulin-like growth factor-I by macro- and microvascular endothelial cells. Endocrinology. 1986;119:1904-1913.
31. Shaddy RE, Hansen CJ, Cowley CG. Effects of T-cell on platelet-derived growth factor-like protein secretion from endothelial cells. J Heart Lung Transplant. 1992;11:48-57.
32. Nabel EG, Yang ZY, Liptay S, San H, Gordon D, Haudenschild CC, Nabel GJ. Recombinant platelet-derived growth factor B gene expression in porcine arteries induces intimal hyperplasia in vivo. J Clin Invest. 1993;91:1822-1829.
33. Phan SH, Gharaee KM, McGarry B, Kunkel SL, Wolber FW. Regulation of rat pulmonary artery endothelial cell transforming growth factor-beta production by IL-1 beta and tumor necrosis factor alpha. J Immunol. 1992;149:103-106.
34. Hosenpud JD, Shipley GD, Wagner CR. Cardiac allograft vasculopathy: current concepts, recent developments, and future directions. J Heart Lung Transplant. 1992;11:9-23.
35. Athreya BH, Pletcher J, Zulian F, Weiner DB, Williams WV. Subset-specific effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro. Clin Immunol Immunopathol. 1993;66:201-211.
36. Pfeifer RW, Patterson RM. Modulation of lectin-stimulaled lymphocyte agglutination and mitogenesis by estrogen metabolites: effects on early events of lymphocyte activation. Arch Toxicol. 1986;58:157-164.
37. Lou H, Zhao Y, Foegh ML. Estradiol in vitro and in vivo inhibits rabbit smooth muscle cell proliferation induced by insulin-like growth factor-1. Circulation. 1995;92(suppl I):1-571. Abstract.
38. Vargas R, Wroblewska B, Rego A, Hatch J, Ramwell PW. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol. 1993;109:612-617.
39. Foegh ML, Asotra S, Howell MH, Ramwell PW. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vasc Surg. 1993;19:722-726.
40. Lou H, Kodama T, Katz N, Foegh M. Chronic estradiol treatment of rabbits with cardiac allografts attenuates graft vascular proliferation induced by insulin-like growth factor-I and interleukin-6. J Am Coll Cardiol. 1995;(special issue):157A. Abstract.
41. Campbell JH, Kocher O, Skalli O, Gabbiani G, Campbell GR. Cytodifferentiation and expression of α-smooth muscle actin mRNA and protein during primary culture of aortic smooth muscle cells: correlation with cell density and proliferative state. Arteriosclerosis. 1989;9:633-643.
42. Thyberg J. Hedin U, Sjölund M, Palmberg L, Bottger BA. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis. 1990;10:966-970.
43. Keogh A, Simmons L, Spratt P, Esmore D, Chang V, Hickie J, Baron D. Hyperlipidemia after heart transplantation. J Heart Transplant. 1988;7:171-175.
44. Rudas L, Pflugfelder PW, Singh NR, Koster WJ. High prevalence of hyperlipidemia following cardiac transplantation. Circulation. 1989;80(suppl II):II-59. Abstract.
45. Sacks FM, McPherson R, Walsh BW. Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations. Arch Intern Meet. 1994;154:1106-1110.
46. Shewmon DA, Stock JL, Rosen CJ, Heiniluoma KM. Hogue MM, Morrison A, Doyle EM, Ukena T, Weale V, Baker S. Tamoxifen and estrogen lower circulating lipoprotein(a) concentrations in healthy postmenopausal women. Arterioscler Thromb. 1994;14:1586-1593.
47. Henriksson P, Stamberger M, Eriksson M, Rudling M, Diczfulusy U, Berglund I, Angelin B. Oestrogen-induced changes in lipoprotein metabolism: role in prevention of atherosclerosis in the cholesterolfed rabbit. Eur J Clin Invest. 1989;19:395-403.
48. Koudy Williams J, Anthony MS, Honore EK, Herrington DM, Morgan TM, Register TC, Clarkson TB. Regression of atherosclerosis in female monkeys. Arterioscler Thromb Vasc Biol. 1995;15:827-836.